相关实验视频

Updated: May 22, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

针对MDS临床问题的全源干细胞移植,选择准备方案和结果

Lara Bischof¹, Jule Ussmann¹, Uwe Platzbecker¹

¹Department for Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany.

Leukemia & lymphoma

|March 12, 2025

概括

异质造血干细胞移植 (allo-HSCT) 是治疗骨髓质瘤 (MDS) 的唯一方法. 本综述讨论了选择MDS患者使用allo-HSCT和复发预防策略的因素.

科学领域:

血液学血液学血液学
在瘤学瘤学.
干细胞移植干细胞移植

背景情况:

骨髓发育性瘤 (MDS) 是一组异质的克隆性造血干细胞疾病.
目前对MDS的治疗选择有限,全源造血干细胞移植 (allo-HSCT) 是唯一潜在的治愈方法.

研究的目的:

总结MDS目前的治疗选择,重点关注allo-HSCT需要考虑的因素.
审查在MDS患者中使用alo-HSCT后预防复发的策略.

主要方法:

对当前治疗指南和与MDS和allo-HSCT相关的临床研究的文献综述.
对MDS不同风险组的alo-HSCT患者选择标准的分析.
对现有和实验性复发预防策略的评估.

主要成果:

艾洛-HSCT是适合,高风险的MDS患者70岁以下的首选治疗方法.
对于年轻,健康,低风险的MDS患者,严重的细胞衰竭不耐保守治疗,可以考虑allo-HSCT.
匹配的捐赠者是首选的,但不匹配的或非相同的捐赠者越来越多地被利用,扩大了MDS患者的捐赠者可用性.

结论:

阿洛-HSCT为MDS提供治疗潜力,仔细选择患者至关重要.
移植后的复发预防策略,包括输注捐赠淋巴细胞和监测MRD或嵌合体变化,是至关重要的.
选择供体和管理潜在的复发是优化MDS的allo-HSCT结果的关键考虑因素.

关键词:

在 MDS MDS 中.骨髓质疏松性瘤是什么所有的HSCT.全基因干细胞移植移植.条件调节方案的调节方案.

更多相关视频

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...